Estrogens in OCs increase the synthesis and activity of clotting factors such as fibrinogen (FI), prothrombin (FII), and factors VII, VIII, and X, while decreasing factor V (FV), which promotes hypercoagulability. This evidence concerns the gene F2 and thrombophilia.